- Home
- HE vs HTFL Comparison
HE vs HTFL Comparison
Compare HE & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HE | HTFL |
|---|---|---|
| Founded | 1891 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | HE | HTFL |
|---|---|---|
| Price | $14.91 | $25.68 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $13.25 | ★ $38.20 |
| AVG Volume (30 Days) | ★ 1.9M | 1.6M |
| Earning Date | 05-08-2026 | 05-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 106.32 | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | ★ $3,086,896,000.00 | N/A |
| Revenue This Year | $16.65 | $27.66 |
| Revenue Next Year | $2.72 | $23.55 |
| P/E Ratio | $21.70 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.06 | $20.13 |
| 52 Week High | $17.33 | $41.22 |
Technical Indicators
Market Signals| Indicator | HE | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 48.86 | 50.25 |
| Support Level | $10.76 | $20.27 |
| Resistance Level | $15.05 | $25.05 |
| Average True Range (ATR) | 0.54 | 1.94 |
| MACD | 0.09 | 0.11 |
| Stochastic Oscillator | 67.90 | 45.22 |
Price Performance
Historical ComparisonAbout HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.